78 related articles for article (PubMed ID: 25267314)
1. Patterns of changing cancer risks with time since diagnosis of a sibling.
Lee M; Czene K; Rebora P; Reilly M
Int J Cancer; 2015 Apr; 136(8):1948-56. PubMed ID: 25267314
[TBL] [Abstract][Full Text] [Related]
2. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
3. Timing of familial breast cancer in sisters.
Rebora P; Czene K; Reilly M
J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer screening, changing age-specific incidence trends and implications on familial risk.
Hemminki K; Rawal R; Bermejo JL
Int J Cancer; 2005 Jan; 113(2):312-5. PubMed ID: 15386407
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
6. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer.
Ellis WJ; Etzioni R; Vessella RL; Hu C; Goodman GE
J Urol; 2001 Jul; 166(1):93-8; discussion 98-9. PubMed ID: 11435831
[TBL] [Abstract][Full Text] [Related]
7. Familial and attributable risks in cutaneous melanoma: effects of proband and age.
Hemminki K; Zhang H; Czene K
J Invest Dermatol; 2003 Feb; 120(2):217-23. PubMed ID: 12542525
[TBL] [Abstract][Full Text] [Related]
8. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
10. Use of disulfiram and risk of cancer: a population-based case-control study.
Askgaard G; Friis S; Hallas J; Thygesen LC; Pottegård A
Eur J Cancer Prev; 2014 May; 23(3):225-32. PubMed ID: 23863824
[TBL] [Abstract][Full Text] [Related]
11. Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes Study.
Magliano DJ; Davis WA; Shaw JE; Bruce DG; Davis TM
Eur J Endocrinol; 2012 Oct; 167(4):589-99. PubMed ID: 22893694
[TBL] [Abstract][Full Text] [Related]
12. Time-space trends in cancer incidence in the Netherlands in 1989-2003.
Siesling S; van der Aa MA; Coebergh JW; Pukkala E;
Int J Cancer; 2008 May; 122(9):2106-14. PubMed ID: 18183593
[TBL] [Abstract][Full Text] [Related]
13. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
[TBL] [Abstract][Full Text] [Related]
14. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
[TBL] [Abstract][Full Text] [Related]
15. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup.
Winawer SJ; Zauber AG; Gerdes H; O'Brien MJ; Gottlieb LS; Sternberg SS; Bond JH; Waye JD; Schapiro M; Panish JF
N Engl J Med; 1996 Jan; 334(2):82-7. PubMed ID: 8531963
[TBL] [Abstract][Full Text] [Related]
16. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
17. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
18. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
[TBL] [Abstract][Full Text] [Related]
19. Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database.
Hemminki K; Chen B
Prostate; 2005 Oct; 65(2):188-94. PubMed ID: 15948149
[TBL] [Abstract][Full Text] [Related]
20. Number of siblings and the risk of solid tumours: a nation-wide study.
Altieri A; Hemminki K
Br J Cancer; 2007 Jun; 96(11):1755-9. PubMed ID: 17453006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
